We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
MSV
426
MN Services Vermogensbeheer
Netherlands
$266K +$5.25K +69 +2%
CCA
427
Cobblestone Capital Advisors
New York
$263K – – –
PI
428
Putnam Investments
Massachusetts
$259K – – –
FAT
429
First American Trust
California
$255K +$1.45K +19 +0.6%
SAMC
430
Shinko Asset Management Company
Japan
$252K -$107K -1,400 -31%
Fifth Third Bancorp
431
Fifth Third Bancorp
Ohio
$242K -$438K -5,754 -66%
IHL
432
Investment House LLC
California
$242K +$5.94K +78 +3%
BCP
433
Blue Chip Partners
Michigan
$241K +$1.14K +15 +0.5%
CC
434
Cognios Capital
Kansas
$238K +$761 +10 +0.3%
OAM
435
Occidental Asset Management
California
$234K -$20.5K -269 -9%
MC
436
Moors & Cabot
Massachusetts
$233K +$221K +2,897 New
Bank of Nova Scotia
437
Bank of Nova Scotia
Ontario, Canada
$232K -$5.45M -71,550 -96%
TCOV
438
Trust Company of Vermont
Vermont
$232K +$83.9K +1,102 +63%
JWA
439
JFS Wealth Advisors
Pennsylvania
$231K -$5.25K -69 -2%
TC
440
TradeLink Capital
Illinois
$229K -$172K -2,265 -45%
FAAS
441
First Allied Advisory Services
California
$228K -$287K -3,773 -57%
FMII
442
Farmers & Merchants Investments Inc
Nebraska
$226K -$5.71K -75 -3%
DILH
443
Dai-ichi Life Holdings
Japan
$221K +$207K +2,716 New
FT
444
Fiduciary Trust
Massachusetts
$217K -$16.8K -220 -8%
HH
445
Hilltop Holdings
Texas
$213K +$199K +2,613 New
W
446
Wealthfront
California
$213K +$200K +2,622 New
EOJOAM
447
E. Ohman J:or Asset Management
Sweden
$212K – – –
EHWM
448
Eads & Heald Wealth Management
Georgia
$209K +$195K +2,565 New
HBT
449
Hills Bank & Trust
Iowa
$206K +$192K +2,525 New
SCM
450
Schnieders Capital Management
California
$206K +$193K +2,534 New
16 17
18
19 20

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.